Analytical control of residual DNA in gene therapy manufacturing

Among the most critical aspects of quality control in gene therapy manufacturing is the quantitation of residual DNA impurities originating from host cells and plasmid materials used during production. However, traditional analytical methods for residual DNA testing, including in-house assay development and compendial approaches, present several challenges. This interactive poster discusses the application of rapid, standardized quantitative qPCR and digital PCR (dPCR) platforms for residual DNA quantification and AAV titration. NEW INTERACTIVE FORMAT Listen to our expert speaker. Watch the video. Read the summary. Focus in on the data. Download the PDF. It has never been easier to quickly access the information you want. All in one place—at the click of a button.

Please enter your email to access content Read now